Displaying 1 - 3 of 3
| Active Ingredient | VITAMIN C |
| Therapeutic Class | VITAMIN C |
| Indications | The treatment and prevention of deficiency . |
| Caution | Usually well tolerated. Large doses are reported to cause diarrhoea and other gastrointestinal disturbances. |
| Dose Range | 25 to 75 mg daily in the p revention of deficiency, and 250 mg or more daily in divided doses for the treatment of deficiency . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ALFACALCIDOL |
| Therapeutic Class | VITAMIN D |
| Indications | Management of hypocalcemia in patients on chronic renal dialysis only. |
| Caution | Not indicated in simple Vitamin D deficiency. Observe calcium levels twice weekly during titration period. |
| Dose Range | 0.25-1mcg daily. Initial dose 0.25 mcg. If a satisfactory response is not achieved, increase dosage by 0.25mcg/day at 4 to 8 week. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCITRIOL |
| Therapeutic Class | VITAMIN D |
| Indications | Management of hypocalcemia in patients on chronic renal dialysis only . |
| Caution | Not indicated in simple Vitamin D deficiency. Observe calcium levels twice weekly during titration period. |
| Dose Range |
0.25-1mcg daily. Initial dose 0.25 mcg. If a satisfactory response is not achieved, increase dosage by 0.25mcg/day at 4 to 8 week. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |